(Q37462316)

20 August 2017

1 reference

title

Reducing the risk of stroke in type 2 diabetes: pathophysiological and therapeutic perspectives (English)

1 reference

20 August 2017

0 references

1 reference

2

Mark T Kearney

1 reference

20 August 2017

Dirk Sander

1

1 reference

20 August 2017

publication date

29 April 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

256

1 reference

20 August 2017

issue

10

1 reference

20 August 2017

page(s)

1603-1619

1 reference

Insulin resistance and thrombogenesis: recent insights and therapeutic implications

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5143-1

Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5143-1

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5143-1

Insulin resistance and risk for stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5143-1

Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5143-1

Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5143-1

Traditional risk factors and ischemic stroke in young adults: the Baltimore-Washington Cooperative Young Stroke Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5143-1

Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5143-1

Diabetes mellitus as a risk factor for death from stroke. Prospective study of the middle-aged Finnish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5143-1

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5143-1

Risk factors for stroke due to cerebral infarction in young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5143-1

Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection.

21 January 2018

1 reference

12 December 2020

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

12 December 2020

Is global cardiovascular risk considered in current practice? Treatment and control of hypertension, hyperlipidemia, and diabetes according to patients' risk level

1 reference

12 December 2020

Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study

1 reference

12 December 2020

Nifedipine retard was as effective as angiotensin converting enzyme inhibitors in preventing cardiac events in high-risk hypertensive patients with diabetes and coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases

1 reference

12 December 2020

Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial

1 reference

12 December 2020

Pioglitazone exerts protective effects against stroke in stroke-prone spontaneously hypertensive rats, independently of blood pressure

1 reference

12 December 2020

The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study

1 reference

12 December 2020

Diabetic and non-diabetic subjects with ischemic stroke: differences, subtype distribution and outcome

1 reference

12 December 2020

Proinflammatory effects of glucose and anti-inflammatory effect of insulin: relevance to cardiovascular disease

1 reference

12 December 2020

High-dose atorvastatin after stroke or transient ischemic attack

1 reference

12 December 2020

Cerebral ischemia-induced apoptosis and necrosis in normal and diabetic rats: effects of insulin and C-peptide

1 reference

12 December 2020

The effect of diabetes and stroke at baseline and during follow-up on stroke mortality

1 reference

12 December 2020

The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control

1 reference

12 December 2020

Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project

1 reference

12 December 2020

Antiplatelet cilostazol is beneficial in diabetic and/or hypertensive ischemic stroke patients. Subgroup analysis of the cilostazol stroke prevention study

1 reference

12 December 2020

Cholesterol and the risk of ischemic stroke

1 reference

12 December 2020

Carotid artery intima-media thickness in patients with Type 2 diabetes mellitus and impaired glucose tolerance: a systematic review

1 reference

12 December 2020

High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review

1 reference

12 December 2020

Factor VIIa and tissue factor procoagulant activity in diabetes mellitus after acute ischemic stroke: impact of hyperglycemia

1 reference

12 December 2020

Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

12 December 2020

Clinical epidemiology of atrial fibrillation and related cerebrovascular events in the United States

1 reference

12 December 2020

Intensive integrated therapy of type 2 diabetes: implications for long-term prognosis

1 reference

12 December 2020

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

1 reference

12 December 2020

Telmisartan to prevent recurrent stroke and cardiovascular events

1 reference

12 December 2020

Autopsy prevalence of intracranial atherosclerosis in patients with fatal stroke

1 reference

12 December 2020

Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT).

1 reference

12 December 2020

Stroke in patients with diabetes mellitus.

1 reference

12 December 2020

Cerebral infarction in diabetes: clinical pattern, stroke subtypes, and predictors of in-hospital mortality

1 reference

12 December 2020

Improving survival with metformin: the evidence base today.

1 reference

12 December 2020

The cardiovascular safety of rosiglitazone

1 reference

12 December 2020

Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification

1 reference

12 December 2020

Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial

1 reference

12 December 2020

Effect of a multifactorial intervention on mortality in type 2 diabetes

1 reference

12 December 2020

Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial

1 reference

12 December 2020

Outcomes with nifedipine GITS or Co-amilozide in hypertensive diabetics and nondiabetics in Intervention as a Goal in Hypertension (INSIGHT).

1 reference

12 December 2020

Diabetes mellitus: a hypercoagulable state

1 reference

12 December 2020

Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes.

1 reference

12 December 2020

Is insulin resistance or diabetes mellitus associated with stroke? An 18-year follow-up study

1 reference

12 December 2020

Risk factors and 20-year stroke mortality in men and women in the Renfrew/Paisley study in Scotland

1 reference

12 December 2020

Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes

1 reference

12 December 2020

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study

1 reference

12 December 2020

Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths

1 reference

12 December 2020

Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Aspirin resistance and diabetes mellitus

1 reference

12 December 2020

The neuroprotection of insulin on ischemic brain injury in rat hippocampus through negative regulation of JNK signaling pathway by PI3K/Akt activation

1 reference

12 December 2020

Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK).

1 reference

12 December 2020

Lipids and stroke: the opportunity of lipid-lowering treatment

1 reference

12 December 2020

Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75).

1 reference

12 December 2020

The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.

1 reference

12 December 2020

The relationship between reduction in low-density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes: an updated meta-analysis

1 reference

12 December 2020

Effects of intensive glucose lowering in type 2 diabetes

1 reference

12 December 2020

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

1 reference

12 December 2020

Diabetic brain damage in hypertension: role of renin-angiotensin system

1 reference

12 December 2020

Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).

1 reference

12 December 2020

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)

1 reference

12 December 2020

Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

1 reference

12 December 2020

Is diabetes mellitus a cardiovascular disease risk equivalent for fatal stroke in women? Data from the Women's Pooling Project

1 reference

12 December 2020

Prediction of cardio- and cerebro-vascular events in patients with subclinical carotid atherosclerosis and low HDL-cholesterol

1 reference

12 December 2020

Risk Factors for Stroke in Type 2 Diabetes Mellitus

1 reference

12 December 2020

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

1 reference

12 December 2020

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

1 reference

12 December 2020

Diabetes mellitus: an independent risk factor for stroke?

1 reference

12 December 2020

Lipid lowering in diabetes mellitus

1 reference

12 December 2020

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis

1 reference

12 December 2020

Prospective Study of Type 1 and Type 2 Diabetes and Risk of Stroke Subtypes: The Nurses' Health Study

1 reference

12 December 2020

Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe

1 reference

12 December 2020

Less benefit from warfarin in diabetics after myocardial infarction?

1 reference

12 December 2020

Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.

1 reference

12 December 2020

Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.

1 reference

12 December 2020

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

1 reference

12 December 2020

Insulin Resistance and Atherosclerosis

1 reference

12 December 2020

A simple deep breathing test reveals altered cerebral autoregulation in type 2 diabetic patients

1 reference

12 December 2020

Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project

1 reference

12 December 2020

Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy

1 reference

12 December 2020

Diabetes, fasting glucose levels, and risk of ischemic stroke and vascular events: findings from the Northern Manhattan Study (NOMAS).

1 reference

12 December 2020

The impact of history of hypertension and type 2 diabetes at baseline on the incidence of stroke and stroke mortality

1 reference

12 December 2020

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

1 reference

12 December 2020

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

12 December 2020

Stroke subtype and mortalitya follow-up study in 998 patients with a first cerebral infarct

1 reference

12 December 2020

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

1 reference

12 December 2020

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

12 December 2020

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

12 December 2020

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

12 December 2020

Low- and high-density lipoprotein cholesterol and ischemic cerebrovascular disease: the bezafibrate infarction prevention registry

1 reference

12 December 2020

Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials

1 reference

12 December 2020

Independent predictors of stroke in patients with atrial fibrillation: a systematic review

1 reference

12 December 2020

Increased plasma levels of 15-deoxyDelta prostaglandin J2 are associated with good outcome in acute atherothrombotic ischemic stroke.

1 reference

12 December 2020

Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion

1 reference

12 December 2020

Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study).

1 reference

12 December 2020

Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus

1 reference

12 December 2020

Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Bezafibrate Infarction Prevention (BIP) Registry: high triglycerides constitute an independent risk factor

1 reference

12 December 2020

Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial

1 reference

12 December 2020

Post-challenge blood glucose concentration and stroke mortality rates in non-diabetic men in London: 38-year follow-up of the original Whitehall prospective cohort study.

1 reference

12 December 2020

Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Intimal neovascularisation is a prominent feature of atherosclerotic plaques in diabetic patients with critical limb ischaemia

1 reference

12 December 2020

Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

1 reference

12 December 2020

Long-term risk factors for stroke: twenty-eight years of follow-up of 7457 middle-aged men in Göteborg, Sweden

1 reference

12 December 2020

Reductions in the risks of recurrent stroke in patients with and without diabetes: the PROGRESS Trial

1 reference

12 December 2020

Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS).

1 reference

12 December 2020

Effects of thiazolidinediones on stroke recovery: a case-matched controlled study

1 reference

12 December 2020

Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials

1 reference

12 December 2020

Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN)

1 reference

12 December 2020

Diabetes mellitus as a prothrombotic condition

1 reference

12 December 2020

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

1 reference

12 December 2020

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

1 reference

12 December 2020

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group

1 reference

12 December 2020

Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky Stroke Study

1 reference

12 December 2020

Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents

1 reference

12 December 2020

Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials

1 reference

12 December 2020

Glycated Hemoglobin and Risk of Stroke in People Without Known Diabetes in the European Prospective Investigation Into Cancer (EPIC)–Norfolk Prospective Population Study

1 reference

12 December 2020

Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease

1 reference

12 December 2020

Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus: meta-analysis of randomised controlled trials

1 reference

12 December 2020

Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial

1 reference

12 December 2020

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

12 December 2020

Incidence of stroke is related to carotid IMT even in the absence of plaque

1 reference

12 December 2020

Blood platelet abnormalities and pharmacological modulation of platelet reactivity in patients with diabetes mellitus

1 reference

12 December 2020

Small dense low-density lipoproteins and associated risk factors in patients with stroke

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

1 reference

12 December 2020

Early benefit from structured care with atorvastatin in patients with coronary heart disease and diabetes mellitus

1 reference

12 December 2020

Statins and stroke prevention

1 reference

12 December 2020

The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region.

1 reference

12 December 2020

Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients: results from the Swedish Trial in Old Patients with Hypertension-2. STOP Hypertension-2 Study Group.

1 reference

12 December 2020

Activation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats

1 reference

12 December 2020

Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus

1 reference

12 December 2020

Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008

1 reference

12 December 2020

Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study

1 reference

12 December 2020

Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study

1 reference

12 December 2020

Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial

1 reference

12 December 2020

Glycaemia (haemoglobin A1c) and incident ischaemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study

1 reference

12 December 2020

Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke: results from PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04)

1 reference

12 December 2020

10.1007/S00415-009-5143-1

Identifiers

DOI

1 reference

20 August 2017

1 reference